Semaglutide is a weight-loss medication that mimics a hormone regulating appetite and food intake. In the UK, it is marketed under the brand names Ozempic (for diabetes) and Wegovy (for obesity). It is prescribed to individuals struggling with weight management, often in conjunction with diet and exercise.

The "Slimming Pen" refers to injectable medications like Saxenda and Wegovy (semaglutide) that help with weight loss. These medications regulate hunger hormones, helping users feel fuller and eat less. They are prescribed for individuals who need additional support in managing their weight, especially when diet and exercise alone aren’t sufficient. They’re increasingly popular in the UK, with potential NHS coverage for certain patients.

The Orbera gastric balloon is a non-surgical, temporary weight-loss device placed in the stomach to reduce food intake. The balloon is inflated and left in place for six months. During that time, patients follow a strict diet and exercise regimen to lose weight. It’s a popular choice for patients who want to avoid invasive surgery.

It is normal to see weight gain after bariatric surgery because patients still live in an obesogenic environment, and the individual's or surgery's ability to control all factors is limited. Body fat is also subject to metabolic pressures to regain lost weight Since salads are typically made of raw fruits and vegetables they can be more difficult to digest. And since you had bariatric surgery your ability to digest foods has changed and will take some time to adjust Over the first three months, patients can expect... +More